The contribution of IL-34 in cancer is also supported by many other studies (Table 1), documenting an enhanced expression of the cytokine in various neoplastic diseases, including hematological malignancies, brain, breast, neck, biliary, and ovarian cancer [37,38]. This evidence concerns the gene IL34 and ovarian cancer.